Wurth Douglas Clark
SEC Form 4 insider trading activity
Wurth Douglas Clark has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: May 18, 2026.
On the most recent filing, Wurth Douglas Clark is listed as Director at Bluejay Diagnostics, Inc. Inside the rolling window, Wurth Douglas Clark reported 1 open-market purchase totaling $25K in BJDX and no open-market sales.
Companies traded
Other insiders at BJDX
Insider Buying
$25K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Wurth Douglas Clark made?
Wurth Douglas Clark has filed 1 SEC Form 4 filing (1 transaction rows) across 1 company since 2026.
Which companies does Wurth Douglas Clark trade?
Wurth Douglas Clark has filed SEC Form 4 disclosures for 1 company, including BJDX.
When was Wurth Douglas Clark's most recent SEC Form 4 filing?
Wurth Douglas Clark's most recent SEC Form 4 filing on Tracefour is dated May 18, 2026.
What is Wurth Douglas Clark's total buy and sell value in the current window?
Inside the rolling retention window, Wurth Douglas Clark bought $25K and sold $0 based on SEC Form 4 filings.
What was Wurth Douglas Clark's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 12,500 BJDX shares on 2026-03-14, worth $25K, per SEC Form 4 filings.